Generalized Lipodystrophy
6 clinical trials · Condition
◉ Watch Generalized Lipodystrophy
| Record | Firm | Date |
|---|---|---|
| Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy (NCT04159415) | Regeneron Pharmaceuticals | 2020-01-07 |
| Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy (NCT04026178) | Aegerion Pharmaceuticals, Inc. | 2018-11-14 |
| Trial of Leptin Replacement Therapy in Patients With Lipodystrophy (NCT00896298) | University of Texas Southwestern Medical Center | 2006-04-01 |
Track Generalized Lipodystrophy automatically
Every clearance here is in the API, with alerts when new ones post.